2019 annual financial data
TG Therapeutics 2019 Operating margin
Direct answer
Operating margin was -111,220.39%.
Operating income was -169,055,000 USD and net income was -172,871,000 USD.
Operating cash flow was -132,806,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,000 USD
- Operating income
- -169,055,000 USD
- Net income
- -172,871,000 USD
- Operating cash flow
- -132,806,000 USD